Search Results Search Sort by RelevanceMost Recent Policy Forum Sep 2006 Should Cost Be a Consideration in Palliative Care? Maria J. Silveira, MD, MA, MPH A physician argues that cost should not be a major consideration in a hospital's decision to provide palliative care services to patients. Virtual Mentor. 2006;8(9):599-601. doi: 10.1001/virtualmentor.2006.8.9.pfor1-0609. In the Literature May 2004 Human Subjects Research for Biochemical Antidotes Susanna Smith A journal author believes human subjects should be used in research on biochemical weapons or their antidotes. Virtual Mentor. 2004;6(5):211-214. doi: 10.1001/virtualmentor.2004.6.5.jdsc1-0405. Case and Commentary Jul 2005 When Diagnosis Becomes Unaffordable, Commentary 1 William Hensel, MD The theme editor introduces a special issue focusing on the challenges of patient access to health care. Virtual Mentor. 2005;7(7):457-460. doi: 10.1001/virtualmentor.2005.7.7.ccas1-0507. Health Law Jun 2005 A Physician's Role in Informing Family Members of Genetic Risk Faith Lagay, PhD Physicians are encouraged not to breach confidentiality by disclosing a patient's genetic information to their offspring or other family members. Virtual Mentor. 2005;7(6):435-437. doi: 10.1001/virtualmentor.2005.7.6.hlaw1-0506. Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 2 Linda MacDonald Glenn, JD, LLM The financial constraints of HMOs often conflict with physicians' medical decisions regarding patient care. Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403. Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 1 Lisa Anderson-Shaw, DrPH, MA, MSN The financial constraints of HMOs often conflict with physicians' medical decisions regarding patient care. Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. In the Literature Nov 2004 Maintaining Integrity in Industry-Sponsored Research Alison Bickford Many ethical and legal issues arise when academic medical research is sponsored by pharmaceutical companies. Virtual Mentor. 2004;6(11):490-493. doi: 10.1001/virtualmentor.2004.6.11.jdsc2-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition. Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Pagination First page « First Previous page ‹ Previous … Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Current page 20 Page 21 Page 22 Next page Next › Last page Last »
Policy Forum Sep 2006 Should Cost Be a Consideration in Palliative Care? Maria J. Silveira, MD, MA, MPH A physician argues that cost should not be a major consideration in a hospital's decision to provide palliative care services to patients. Virtual Mentor. 2006;8(9):599-601. doi: 10.1001/virtualmentor.2006.8.9.pfor1-0609.
In the Literature May 2004 Human Subjects Research for Biochemical Antidotes Susanna Smith A journal author believes human subjects should be used in research on biochemical weapons or their antidotes. Virtual Mentor. 2004;6(5):211-214. doi: 10.1001/virtualmentor.2004.6.5.jdsc1-0405.
Case and Commentary Jul 2005 When Diagnosis Becomes Unaffordable, Commentary 1 William Hensel, MD The theme editor introduces a special issue focusing on the challenges of patient access to health care. Virtual Mentor. 2005;7(7):457-460. doi: 10.1001/virtualmentor.2005.7.7.ccas1-0507.
Health Law Jun 2005 A Physician's Role in Informing Family Members of Genetic Risk Faith Lagay, PhD Physicians are encouraged not to breach confidentiality by disclosing a patient's genetic information to their offspring or other family members. Virtual Mentor. 2005;7(6):435-437. doi: 10.1001/virtualmentor.2005.7.6.hlaw1-0506.
Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 2 Linda MacDonald Glenn, JD, LLM The financial constraints of HMOs often conflict with physicians' medical decisions regarding patient care. Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403.
Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 1 Lisa Anderson-Shaw, DrPH, MA, MSN The financial constraints of HMOs often conflict with physicians' medical decisions regarding patient care. Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
In the Literature Nov 2004 Maintaining Integrity in Industry-Sponsored Research Alison Bickford Many ethical and legal issues arise when academic medical research is sponsored by pharmaceutical companies. Virtual Mentor. 2004;6(11):490-493. doi: 10.1001/virtualmentor.2004.6.11.jdsc2-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition. Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.